loader
Please Wait
Applying Filters...

Looking for Daclatasvir? Find Controlled & Modified Release used in Daclatasvir to address drug delivery challenges on PharmaCompass.

Menu
$ API Ref.Price (USD/KG) : 654Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1SPI Pharma

02 2Ideal Cures Pvt Ltd

03 14Kerry

04 1Kima Chemical

05 1Lonza Capsugel

06 1Sigachi Industries

07 2The Dow Chemical Company

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSPI Pharma has been solving formulation challenges using superior functional materials.

04

arrow
Pittcon 2025
Not Confirmed

08

arrow
Pittcon 2025
Not Confirmed
arrow
Pittcon 2025
Not Confirmed

Brand : METHOCEL™

Applications : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Pharmacopoeia Ref : Not Available

Technical Specs : Not Available

Grade : Not Available

arrow
blank

14

arrow
Pittcon 2025
Not Confirmed
arrow
Pittcon 2025
Not Confirmed

Brand : VCAPS® ENTERIC

Applications : It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.

Pharmacopoeia Ref : Complies with relevant European, Japanese and US Pharmacopeia monographs

Technical Specs : Water content – less than 6%; Size #0

Grade : Oral

arrow
blank